Modeling the Health Economic Burden of Hepatitis C Virus Infection in Turkey: Cost-Effectiveness of Targeted Screening
Turkish Journal of Gastroenterology · 2023
DOI: 10.5152/tjg.2023.22749 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Turkish Journal of Gastroenterology, 2023. Verfasst von Ayhan Hilmi Çekin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Health Sciences University Antalya Training and Research Hospital, Antalya, Turkey. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Substance Abuse, Intravenous, Hepatitis C. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aims: In 2016, World Health Organization introduced global goals to eliminate hepatitis C virus by 2030. The aim of this study is to analyze the epidemiologic and economic burden of hepatitis C virus in Turkey and compare current practice (regular care) with a hypothetical active screening and treatment approach (active scenario). Materials and Methods: A Markov model was used to analyze and compare regular care with a scenario developed by experts including the screening and treatment of all acute and chronic hepatitis C virus infections between 2020 and 2050. General and targeted populations were focused. The model reflected the natural history of the disease, and the inputs were based on a literature review and expert opinions. Costs were provided by previous studies and national regulations.
Results
The active scenario resulted in higher spending for all groups compared with regular care in the first year. Cumulative costs were equalized in the 8th, 12th, 13th, and 16th year and followed by cost-savings of 49.7 million, 1.1 billion, 288.6 million, and 883.4 million Turkish liras in 20 years for prisoners, refugees, people who inject drugs (PWID), and all population, respectively. In all groups, the mortality was found to be lower with the active scenario. In total, 62.8% and 50.6% of expected deaths with regular care in 5 and 20 years, respectively, were prevented with the active scenario.
Conclusions
An active screening and treatment approach for hepatitis C virus infection could be cost-effective for PWID, prisoners, and refugees. Almost two-thirds of deaths in regular care could be prevented in 5 years’ time with this approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Health Sciences University Antalya Training and Research Hospital, Antalya, Turkey.
- Department of Infectious Diseases and Clinical Microbiology, Ministry of Health Ankara City Hospital, Ankara, Turkey.
- Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
- Department of Gastroenterology, Güven Hospital, Ankara, Turkey.
- Department of Medical Education, İstanbul Health and Technology University, İstanbul, Turkey.
- Department of Infectious Diseases and Clinical Microbiology, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Zitieren
APA
Çekin, A. H., Güner, R., Çağkan İnkaya, A., Oğuz, D., Özdemir, O., & Tabak, Ö. F. (2023). Modeling the Health Economic Burden of Hepatitis C Virus Infection in Turkey: Cost-Effectiveness of Targeted Screening. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2023.22749
Vancouver
Çekin AH, Güner R, Çağkan İnkaya A, Oğuz D, Özdemir O, Tabak ÖF. Modeling the Health Economic Burden of Hepatitis C Virus Infection in Turkey: Cost-Effectiveness of Targeted Screening. Turkish Journal of Gastroenterology. 2023. doi:10.5152/tjg.2023.22749
BibTeX
@article{ekin2023,
author = {Çekin, Ayhan Hilmi and Güner, Rahmet and Çağkan İnkaya, Ahmet and Oğuz, Dilek and Özdemir, Oktay and Tabak, Ömer Fehmi},
title = {Modeling the Health Economic Burden of Hepatitis C Virus Infection in Turkey: Cost-Effectiveness of Targeted Screening},
journal = {Turkish Journal of Gastroenterology},
year = {2023},
doi = {10.5152/tjg.2023.22749}
}
EUVIMED